Skip Navigation


Carcinogenesis Advance Access originally published online on December 6, 2005
Carcinogenesis 2006 27(4):682-692; doi:10.1093/carcin/bgi298
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
27/4/682    most recent
bgi298v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Google Scholar
Right arrow Articles by O'Brien, V.
Right arrow Articles by Brown, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O'Brien, V.
Right arrow Articles by Brown, R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

REVIEW

Signalling cell cycle arrest and cell death through the MMR System

Vincent O'Brien * and Robert Brown

Centre for Oncology and Applied Pharmacology, Cancer Research UK Beatson Laboratories, Garscube Estate, Glasgow G61 1BD, UK

* To whom correspondence should be addressed. Tel: +44 0141 330 4125; Fax: +44 0141 330 4127; Email: v.obrien{at}beatson.gla.ac.uk

Loss of DNA mismatch repair (MMR) in mammalian cells, as well as having a causative role in cancer, has been linked to resistance to certain DNA damaging agents including clinically important cytotoxic chemotherapeutics. MMR-deficient cells exhibit defects in G2/M cell cycle arrest and cell killing when treated with these agents. MMR-dependent cell cycle arrest occurs, at least for low doses of alkylating agents, only after the second S-phase following DNA alkylation, suggesting that two rounds of DNA replication are required to generate a checkpoint signal. These results point to an indirect role for MMR proteins in damage signalling where aberrant processing of mismatches leads to the generation of DNA structures (single-strand gaps and/or double-strand breaks) that provoke checkpoint activation and cell killing. Significantly, recent studies have revealed that the role of MMR proteins in mismatch repair can be uncoupled from the MMR-dependent damage responses. Thus, there is a threshold of expression of MSH2 or MLH1 required for proper checkpoint and cell-death signalling, even though sub-threshold levels are sufficient for fully functional MMR repair activity. Segregation is also revealed through the identification of mutations in MLH1 or MSH2 that provide alleles functional in MMR but not in DNA damage responses and mutations in MSH6 that compromise MMR but not in apoptotic responses to DNA damaging agents. These studies suggest a direct role for MMR proteins in recognizing and signalling DNA damage responses that is independent of the MMR catalytic repair process. How MMR-dependent G2 arrest may link to cell death remains elusive and we speculate that it is perhaps the resolution of the MMR-dependent G2 cell cycle arrest following DNA damage that is important in terms of cell survival.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
H. Feitsma, A. Akay, and E. Cuppen
Alkylation damage causes MMR-dependent chromosomal instability in vertebrate embryos
Nucleic Acids Res., July 1, 2008; 36(12): 4047 - 4056.
[Abstract] [Full Text] [PDF]

Home page
 MutagenesisHome page
H. Feitsma, E. de Bruijn, J. van de Belt, I. J. Nijman, and E. Cuppen
Mismatch repair deficiency does not enhance ENU mutagenesis in the zebrafish germ line
Mutagenesis, July 1, 2008; 23(4): 325 - 329.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Caporali, L. Levati, G. Starace, G. Ragone, E. Bonmassar, E. Alvino, and S. D'Atri
AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition
Mol. Pharmacol., July 1, 2008; 74(1): 173 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Gurkan, J. E. Schupp, M. A. Aziz, T. J. Kinsella, and K. A. Loparo
Probabilistic Modeling of DNA Mismatch Repair Effects on Cell Cycle Dynamics and Iododeoxyuridine-DNA Incorporation
Cancer Res., November 15, 2007; 67(22): 10993 - 11000.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. A. Flanagan, B. W. Robinson, C. M. Krokosky, and D. S. Shewach
Mismatched nucleotides as the lesions responsible for radiosensitization with gemcitabine: a new paradigm for antimetabolite radiosensitizers
Mol. Cancer Ther., June 1, 2007; 6(6): 1858 - 1868.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
X. Zeng, T. Yan, J. E. Schupp, Y. Seo, and T. J. Kinsella
DNA Mismatch Repair Initiates 6-Thioguanine-Induced Autophagy through p53 Activation in Human Tumor Cells
Clin. Cancer Res., February 15, 2007; 13(4): 1315 - 1321.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. R. Hart, O. Glebov, R. J. Ernst, I. R. Kirsch, and J. K. Barton
DNA mismatch-specific targeting and hypersensitivity of mismatch-repair-deficient cells to bulky rhodium(III) intercalators
PNAS, October 17, 2006; 103(42): 15359 - 15363.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.